CDKN2A and acute myeloid leukemia: Wang et al. [90] found that lncRNA antisense non-coding RNA at the INK4 locus (ANRIL) is overexpressed in acute myeloid leukemia (AML) patients and promotes disease development and progression via the modulation of glucose metabolism.